S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:APLSApellis Pharmaceuticals Earnings Date, Estimates & History

$26.91
-0.75 (-2.71 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$26.85
Now: $26.91
$28.33
50-Day Range
$25.89
MA: $30.15
$33.65
52-Week Range
$16.85
Now: $26.91
$45.04
Volume521,800 shs
Average Volume1.16 million shs
Market Capitalization$2.03 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.09

Earnings

Apellis Pharmaceuticals (NASDAQ:APLS) Earnings Information

Apellis Pharmaceuticals last announced its earnings data on July 31st, 2020. The reported ($1.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.34) by $0.24. Apellis Pharmaceuticals has generated ($4.64) earnings per share over the last year. Apellis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Apellis Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Apellis Pharmaceuticals (NASDAQ:APLS) Earnings Estimates

2020 EPS Consensus Estimate: ($5.23)
2021 EPS Consensus Estimate: ($5.23)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($1.35)($1.03)($1.21)
Q2 20203($1.36)($1.09)($1.26)
Q3 20203($1.43)($1.22)($1.35)
Q4 20203($1.53)($1.26)($1.40)
Q1 20211($1.29)($1.29)($1.29)
Q2 20211($1.34)($1.34)($1.34)
Q3 20211($1.33)($1.33)($1.33)
Q4 20211($1.27)($1.27)($1.27)

Apellis Pharmaceuticals (NASDAQ APLS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)
       
7/31/2020Q2($1.3350)($1.57)($1.57)N/A
4/29/2020Q1 2020($1.38)($2.29)($2.29)N/A
2/27/2020Q4 2019($1.14)($1.77)($1.63)N/A
11/5/2019Q3($1.0120)($1.10)($1.10)N/A
7/31/2019Q2 2019($0.80)($0.98)($0.84)N/A
5/8/2019Q1($0.6680)($0.87)($0.87)N/A
2/26/2019Q4 2018($0.65)($0.65)($0.65)N/A
11/13/2018Q3 2018($0.6870)($0.64)($0.64)N/A
7/31/2018Q2 2018($0.47)($0.61)($0.61)N/A
4/30/2018Q1 2018($0.3250)($0.43)($0.43)N/A
3/19/2018Q4 2017($0.27)($0.60)($0.59)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.